Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$5.99 - $24.97 $8.82 Million - $36.8 Million
-1,472,624 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$20.0 - $27.43 $18,000 - $24,687
-900 Reduced 0.06%
1,472,624 $36.9 Million
Q2 2021

Aug 13, 2021

SELL
$24.34 - $38.34 $1.51 Million - $2.39 Million
-62,212 Reduced 4.05%
1,473,524 $39.6 Million
Q1 2021

May 14, 2021

BUY
$24.74 - $40.2 $38 Million - $61.7 Million
1,535,736 New
1,535,736 $43.7 Million

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $141M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Carmignac Gestion Portfolio

Follow Carmignac Gestion and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Carmignac Gestion with notifications on news.